The DOI matches its Crossref record; 94 of the 97 references it cites were found in a registry or an index.
Complications of Viral Influenza
Open accessAbstract
Viral influenza is a seasonal infection associated with significant morbidity and mortality. In the United States more than 35,000 deaths and 200,000 hospitalizations due to influenza occur annually, and the number is increasing. Children aged less than 1 year and adults aged more than 65 years, pregnant woman, and people of any age with comorbid illnesses are at highest risk. Annual vaccination is the cornerstone of prevention, but some older patients may derive less benefit from immunization than otherwise fit individuals. If started promptly, antiviral medications may reduce complications of acute influenza, but increasing resistance to amantadine and perhaps neuraminidase inhibitors underscores the need for novel prevention and treatment strategies. Pulmonary complications of influenza are most common and include primary influenza and secondary bacterial infection. Either may cause pneumonia, and each has a unique clinical presentation and pathologic basis. Staphylococcus aureus, including methicillin-resistant strains, is an important cause of secondary bacterial pneumonia with high mortality. During influenza season, treatment of pneumonia should include empiric coverage for this pathogen. Neuromuscular and cardiac complications are unusual but may manifest in persons of any age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The spread of bacteria such as methicillin-resistant Staphylococcus aureus and highly pathogenic clones of Streptococcus pyogenes pose more general risks [86].”
From Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness (2008) · cites this paper as [86]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,045
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,182
Fiore, A. E., Shay, D. K., Broder, K. R., Iskander, J. K., Uyeki, T. M., Mootrey, G., Bresee, J. S., & Cox, N. S. (2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,006
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Influenza-Associated Hospitalizations in the United States
Thompson, W. W. (2004) · JAMA · doi:10.1001/jama.292.11.1333 · Cited by 2,213
Avian Influenza A (H5N1) Infection in Humans
The Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5 (2005) · New England Journal of Medicine · doi:10.1056/nejmra052211 · Cited by 1,294
Avian Influenza Virus (H5N1): a Threat to Human Health
Peiris, M. J. S., de Jong, M. D., & Guan, Y. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-06 · Cited by 1,030
Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza
Treanor, J. J., Hayden, F. G., Vrooman, P., Barbarash, R. A., Bettis, R. B., Riff, D. S., Singh, S., Kinnersley, N., Ward, P., Mills, R., et al. (2000) · JAMA · doi:10.1001/jama.283.8.1016 · Cited by 1,019
Influenza and the Rates of Hospitalization for Respiratory Disease among Infants and Young Children
Izurieta, H. S., Thompson, W., Kramarz, P., Shay, D. K., Davis, R. L., Destefano, F. R., BLACK, S. B., Shinefield, H. R., & Fukuda, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001273420402 · Cited by 1,013
Oseltamivir Resistance during Treatment of Influenza A (H5N1) Infection
de Jong, M. D., Thanh, T. T., Khanh, T. H., Hien, V. M., Smith, G. J. D., Chau, N. V., Cam, B. V., Qui, P. T., Ha, D. Q., Guan, Y., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa054512 · Cited by 900
Research works printed but not linked: 2
- Simonsen, 2005, Researchers defend influenza vaccine study, Infectious Disease News
- Beigel, 2005, Avian influenza A (H5N1) infection in humans, N Engl J Med, 353, 1374, 10.1056/NEJMra052211 · DOI
Cited by
Sorted by citations
Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/591708 · Cited by 1,625
“The spread of bacteria such as methicillin-resistant Staphylococcus aureus and highly pathogenic clones of Streptococcus pyogenes pose more general risks [86].”
BackgroundRespiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology
Tregoning, J. S., & Schwarze, J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00032-09 · Cited by 768
Paules, C. I., & Subbarao, K. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30129-0 · Cited by 786
Immunity and immunopathology to viruses: what decides the outcome?
Rouse, B. T., & Sehrawat, S. (2010) · Nature reviews. Immunology · doi:10.1038/nri2802 · Cited by 636
Imaging of Pulmonary Viral Pneumonia
Franquet, T. (2011) · Radiology · doi:10.1148/radiol.11092149 · Cited by 380
Bacterial co‐infections with SARS‐CoV ‐2
Mirzaei, R., Goodarzi, P., Asadi, M., Soltani, A., Aljanabi, H. A. A., Jeda, A. S., Dashtbin, S., Jalalifar, S., Mohammadzadeh, R., Teimoori, A., et al. (2020) · IUBMB Life · doi:10.1002/iub.2356 · Cited by 304
Rondy, M., El Omeiri, N., Thompson, M. G., Levêque, A., Moren, A., & Sullivan, S. G. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.09.010 · Cited by 247
Jorgensen, P., Mereckiene, J., Cotter, S. M., Johansen, K., Tsolova, S., & Brown, C. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.12.019 · Cited by 249
Sullivan, S. J., Jacobson, R. M., Dowdle, W. R., & Poland, G. A. (2009) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0588 · Cited by 228
Outcomes of adults hospitalised with severe influenza
Lee, N. L. S., Choi, K. W. Y., Chan, P. K. S., Hui, D. S. C., Lui, G. C.-Y., Wong, B. C. K., Wong, R. Y. K., Sin, W. Y., Hui, W. M., Ngai, K. L. K., et al. (2010) · Thorax · doi:10.1136/thx.2009.130799 · Cited by 209
Viral–bacterial co-infections in the respiratory tract
Bakaletz, L. O. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.11.003 · Cited by 207
Modeling Host Genetic Regulation of Influenza Pathogenesis in the Collaborative Cross
Ferris, M. T., Aylor, D. L., Bottomly, D., Whitmore, A. C., Aicher, L. D., Bell, T. A., Bradel-Tretheway, B., Bryan, J. T., Buus, R. J., Gralinski, L. E., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003196 · Cited by 190
Serrano‐Aroca, Á., Takayama, K., Tuñón‐Molina, A., Seyran, M., Hassan, S. S., Choudhury, P. P., Uversky, V. N., Lundstrom, K. H., Adadi, P., Palù, G., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c00629 · Cited by 183
Immune responses after live attenuated influenza vaccination
Mohn, K. G.-I., Smith, I., Sjursen, H., & Cox, R. J. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1377376 · Cited by 179
Influenza vaccination in the elderly
Smetana, J., Chlíbek, R., Shaw, J., Špliňo, M., & Prymula, R. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1343226 · Cited by 172
Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia
Yang, Y., & Tang, H. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.1 · Cited by 165
van den Brand, J. M. A., Haagmans, B. L., van Riel, D. A. J., Osterhaus, A. D. M. E., & Kuiken, T. (2014) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2014.01.004 · Cited by 161
Vírseda, S., Restrepo, M. A., Arranz, E., Tapia, P. M., Fernández‐Ruiz, M., de la Cámara, A. G., Aguado, J. M., & López‐Medrano, F. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.04.101 · Cited by 142
Bench-to-bedside review: Bacterial pneumonia with influenza - pathogenesis and clinical implications
van der Sluijs, K. F., van der Poll, T., Lutter, R., Juffermans, N. P., & Schultz, M. J. (2010) · Critical Care · doi:10.1186/cc8893 · Cited by 136
Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future
Trombetta, C. M., Perini, D., Mather, S. T., Temperton, N. J., & Montomoli, E. (2014) · Vaccines · doi:10.3390/vaccines2040707 · Cited by 116
Coleman, B. L., Sanderson, R., Haag, M. D. M., & McGovern, I. (2021) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12871 · Cited by 117
Global Burden of Influenza as a Cause of Cardiopulmonary Morbidity and Mortality
Fischer, W. A., Gong, M. N., Bhagwanjee, S., & Sevransky, J. (2014) · Global Heart · doi:10.1016/j.gheart.2014.08.004 · Cited by 118
Augmented Lung Inflammation Protects against Influenza A Pneumonia
Tuvim, M. J., Evans, S. E., Clement, C. G., Dickey, B. F., & Gilbert, B. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004176 · Cited by 109
Network-based analysis of comorbidities risk during an infection: SARS and HIV case studies
Moni, M. A., & Lió, P. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-333 · Cited by 106
Clinical review: Primary influenza viral pneumonia
Rello, J., & Pop-Vicas, A. E. (2009) · Critical Care · doi:10.1186/cc8183 · Cited by 109
Zhao, C., Li, X., Li, L., Cheng, G., Gong, X., & Zheng, J. (2013) · Langmuir · doi:10.1021/la304511s · Cited by 102
Synergistic TLR2/6 and TLR9 Activation Protects Mice against Lethal Influenza Pneumonia
Tuvim, M. J., Gilbert, B. E., Dickey, B. F., & Evans, S. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030596 · Cited by 101
The burden of influenza complications in different high-risk groups: a targeted literature review
Mauskopf, J., Klesse, M., Lee, S., & Herrera‐Taracena, G. (2012) · Journal of Medical Economics · doi:10.3111/13696998.2012.752376 · Cited by 99
Liang, C., Zheng, D., Lee, Y. H., Chan, T. K., Kumar, Y., Ho, W. E., Chen, J. Z., Tannenbaum, S. R., & Ong, C. N. (2016) · Scientific Reports · doi:10.1038/srep26076 · Cited by 99
Kugel, D., Kochs, G., Obojes, K., Roth, J., Kobinger, G., Kobasa, D., Haller, O., Staeheli, P., & von Messling, V. (2009) · Journal of Virology · doi:10.1128/jvi.02453-08 · Cited by 101
Reed, C., Chaves, S. S., Pérez, A., D'Mello, T. A., Kirley, P. D., Aragon, D., Meek, J. I., Farley, M. M., Ryan, P., Lynfield, R., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu285 · Cited by 98
Fell, D. B., Azziz‐Baumgartner, E., Baker, M. G., Batra, M., Beauté, J., Beutels, P., Bhat, N., Bhutta, Z. A., Cohen, C., Mucio, B. D., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.08.037 · Cited by 100
Loving, C. L., Brockmeier, S. L., Vincent, A. L., Palmer, M. V., Sacco, R. E., & Nicholson, T. L. (2010) · Microbial Pathogenesis · doi:10.1016/j.micpath.2010.06.004 · Cited by 95
Influenza-Like Illness Sentinel Surveillance in Peru
Laguna-Torres, V. A., Gómez, J., Ocaña, V., Aguilar, P., Saldarriaga, T., Chávez-Cruzado, E., Perez, J., Zamalloa, H., Forshey, B. M., Paz, I., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006118 · Cited by 96
Dietert, R. R., DeWitt, J. C., Germolec, D. R., & Zelikoff, J. T. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.1001971 · Cited by 97
Ryan, L. K., Dai, J., Yin, Z., Megjugorac, N. J., Uhlhorn, V., Yim, S., Schwartz, K., Abrahams, J. M., Diamond, G., & Fitzgerald-Bocarsly, P. A. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0209079 · Cited by 95
Epidemiology and Management of Common Pulmonary Diseases in Older Persons
Akgun, K. M., Crothers, K. A., & Pisani, M. A. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr251 · Cited by 95
Role of infection in the development and exacerbation of asthma
Guilbert, T. W., & Denlinger, L. C. (2010) · Expert Review of Respiratory Medicine · doi:10.1586/ers.09.60 · Cited by 94
Novel Influenza Virus NS1 Antagonists Block Replication and Restore Innate Immune Function
Basu, D., Walkiewicz, M. P., Frieman, M. B., Baric, R. S., Auble, D., & Engel, D. A. (2008) · Journal of Virology · doi:10.1128/jvi.01805-08 · Cited by 93
Valuing the broader benefits of dengue vaccination, with a preliminary application to Brazil
Bärnighausen, T., Bloom, D. E., Cafiero, E. T., & O’Brien, J. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.04.010 · Cited by 88
Garg, S., Jain, S., Dawood, F. S., Jhung, M. A., Pérez, A., D'Mello, T. A., Reingold, A. L., Gershman, K., Meek, J. I., Arnold, K. E., et al. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1004-y · Cited by 90
Keilich, S. R., Bartley, J. M., & Haynes, L. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2019.103992 · Cited by 92
PPAR-γ Activation As an Anti-inflammatory Therapy for Respiratory Virus Infections
Bassaganya-Riera, J., Song, R., Roberts, P. C., & Hontecillas, R. (2010) · Viral Immunology · doi:10.1089/vim.2010.0016 · Cited by 83
The Burden of Influenza Hospitalizations in Infants From 2003 to 2012, United States
Chaves, S. S., Pérez, A., Farley, M. M., Miller, L. A., Schaffner, W., Lindegren, M. L., Sharangpani, R., Meek, J. I., Yousey-Hindes, K. M., Thomas, A. R., et al. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000321 · Cited by 76
Renal complications of seasonal and pandemic influenza A virus infections
Watanabe, T. (2012) · European Journal of Pediatrics · doi:10.1007/s00431-012-1854-x · Cited by 77
Germacrone inhibits early stages of influenza virus infection
Liao, Q., Qian, Z., Liu, R., An, L., & Chen, X. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.09.021 · Cited by 77
Löffler, B., Niemann, S., Ehrhardt, C., Horn, D., Lanckohr, C., Lina, G., Ludwig, S., & Peters, G. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2013.827891 · Cited by 79
SARS‐CoV‐2, COVID‐19, skin and immunology – What do we know so far?
Novak, N., Peng, W., Nägeli, M., Galvan, C., Kolm‐Djamei, I., Brüggen, M., Cabanillas, B., Schmid‐Grendelmeier, P., & Català, A. (2020) · Allergy · doi:10.1111/all.14498 · Cited by 73
Impact of aging on viral infections
Leng, J., & Goldstein, D. R. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.08.009 · Cited by 76
Maher, L., Hope, K. G., Torvaldsen, S., Lawrence, G. L., Dawson, A. J., Wiley, K. E., Thomson, D., Hayen, A. D., & Conaty, S. J. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.08.081 · Cited by 77
Shi, S. J., Li, H., Liu, M., Liu, Y. M., Zhou, F., Liu, B., Qu, J. X., & Cao, B. (2015) · The Clinical Respiratory Journal · doi:10.1111/crj.12346 · Cited by 75
Exploring Sex and Gender in Bioarchaeology
Agarwal, S. C., & Wesp, J. K. (2017) · Project Muse (Johns Hopkins University) · Cited by 76
Innate immunity and inflammation – two facets of the same anti-infectious reaction
Si‐Tahar, M., Touqui, L., & Chignard, M. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03893.x · Cited by 75
Socioeconomic Impact of Seasonal (Epidemic) Influenza and the Role of Over-the-Counter Medicines
Klepser, M. E. (2014) · Drugs · doi:10.1007/s40265-014-0245-1 · Cited by 72
Mårild, K., Fredlund, H., & Ludvigsson, J. F. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.352 · Cited by 70
Saito, K., Shobugawa, Y., Aida, J., & Kondo, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-86854-3 · Cited by 69
Buda, S., Tolksdorf, K., Schuler, E., Kuhlen, R., & Haas, W. (2017) · BMC Public Health · doi:10.1186/s12889-017-4515-1 · Cited by 69
Mak, D. B., Regan, A. K., Joyce, S., Gibbs, R. A., & Effler, P. V. (2014) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12292 · Cited by 71
Martí, M., Tuñón‐Molina, A., Aachmann, F. L., Muramoto, Y., Noda, T., Takayama, K., & Serrano‐Aroca, Á. (2021) · Polymers · doi:10.3390/polym13020207 · Cited by 66
Wee, J. L. K., Scheerlinck, J. Y., Snibson, K. J., Edwards, S. J., Pearse, M. J., Quinn, C. T., & SUTTON, P. R. N. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.59 · Cited by 65
Middleton, E. A., Rondina, M. T., Schwertz, H., & Zimmerman, G. A. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0420tr · Cited by 64
Furushima, D., Ide, K., & Yamada, H. (2018) · Molecules · doi:10.3390/molecules23071795 · Cited by 64
Severe Pneumonia Associated with Pandemic (H1N1) 2009 Outbreak, San Luis Potosí, Mexico
Gómez‐Gómez, A., Magaña-Aquino, M., García-Sepúlveda, C. A., Ochoa-Pérez, U. R., Falcón-Escobedo, R., Comas‐García, A., Aranda‐Romo, S., Contreras-Treviño, H. I., Jiménez-Rico, P. V., Banda-Barbosa, M. A., et al. (2009) · Emerging infectious diseases · doi:10.3201/eid1601.090941 · Cited by 60
MicroRNA-155 regulates host immune response to postviral bacterial pneumonia via IL-23/IL-17 pathway
Podsiad, A. B., Standiford, T. J., Ballinger, M. N., Eakin, R., Park, P. K., Kunkel, S. L., Moore, B. B., & Bhan, U. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00224.2015 · Cited by 63
Viruses Associated With Pneumonia in Adults
Cesario, T. C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis297 · Cited by 60
Influenza A, Influenza B, and SARS-CoV-2 Similarities and Differences – A Focus on Diagnosis
Havasi, A. D., Vișan, S., Cainap, C. I., Cainap, S. S., MIHAILA, A. A., & Pop, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.908525 · Cited by 58
Future antiviral polymers by plasma processing
Ma, C., Nikiforov, A. Y., Geyter, N. D., Dai, X., Morent, R., & Ostrikov, K. (2021) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2021.101410 · Cited by 58
Economic and Behavioral Influencers of Vaccination and Antimicrobial Use
Wagner, C. E., Prentice, J. A., Saad-Roy, C. M., Yang, L., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.614113 · Cited by 56
Clinical characteristics of children and adults hospitalized for influenza virus infection
Leung, C.-H., Tseng, H.-K., Wang, W., Chiang, H.-T., Wu, A. Y.-J., & Liu, C.-P. (2013) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2013.06.002 · Cited by 56
Improving influenza vaccination coverage in pregnancy in M elbourne 2010–2011
McCarthy, E. A., Pollock, W., Nolan, T. M., Hay, S., & McDonald, S. (2012) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2012.01428.x · Cited by 57
Payment in challenge studies: ethics, attitudes and a new payment for risk model
Grimwade, O., Savulescu, J., Giubilini, A., Oakley, J. G., Osowicki, J., Pollard, A. J., & Nußberger, A.-M. (2020) · Journal of Medical Ethics · doi:10.1136/medethics-2020-106438 · Cited by 51
The Tamiflu fiasco and lessons learnt
Gupta, Y., Meenu, M., & Mohan, P. (2015) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.150308 · Cited by 53
Respiratory and Nonrespiratory Diagnoses Associated With Influenza in Hospitalized Adults
Chow, E. J., Rolfes, M. A. R., O’Halloran, A. C., Alden, N. B., Anderson, E. J., Bennett, N. M., Billing, L. M., Dufort, E. M., Kirley, P. D., George, A., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.1323 · Cited by 53
Stemerding, A. M., Köhl, J., Pandey, M. K., Kuipers, A., Leusen, J. H. W., Boross, P., Nederend, M., Vidarsson, G., Weersink, A. J. L., van de Winkel, J. G. J., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203243 · Cited by 53
Aebi, T., Weisser, M., Bucher, E., Hirsch, H. H., Marsch, S., & Siegemund, M. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-308 · Cited by 51
Tamura, D., Sugaya, N., Ozawa, M., Takano, R., Ichikawa, M., Yamazaki, M., Kawakami, C., Shimizu, H., Uehara, R., Kiso, M., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq183 · Cited by 50
Arnold, L. D., Luong, L., Rebmann, T., & Chang, J. J. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.02.014 · Cited by 51
Ion flux in the lung: virus-induced inflammasome activation
Triantafilou, K., & Triantafilou, M. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.06.002 · Cited by 47
Walsh, L. K., Donelle, J., Dodds, L. A., Hawken, S., Wilson, K. R., Benchimol, E. I., Chakraborty, P. K., Guttmann, A., Kwong, J. C., MacDonald, N. E., et al. (2019) · BMJ · doi:10.1136/bmj.l4151 · Cited by 51
EHLKEN, B., Anastassopoulou, A., Hain, J., Schröder, C., & Wahle, K. (2015) · BMC Public Health · doi:10.1186/s12889-015-1885-0 · Cited by 47
van Doorn, E., Liu, H., Ben-Yedidia, T., Hassin, S., Visontai, I., Norley, S., Frijlink, H. W., & Hak, E. (2017) · Medicine · doi:10.1097/md.0000000000006339 · Cited by 47
Rapid death of duck cells infected with influenza: a potential mechanism for host resistance to H5N1
Kuchipudi, S. V., Dunham, S. P., Nelli, R. K., White, G. A., Coward, V. J., Slomka, M. J., Brown, I. H., & Chang, K. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.17 · Cited by 46
Relationship of Th1/Th2 cell balance with the immune response to influenza vaccine during pregnancy
Yamaguchi, K., Hisano, M., Isojima, S., Irie, S., Arata, N., Watanabe, N., Kubo, T., Kato, T., & Murashima, A. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21620 · Cited by 46
Epidemiology and cost of seasonal influenza in Germany - a claims data analysis
Scholz, S. M., Damm, O., Schneider, U., Ultsch, B., Wichmann, O., & Greiner, W. (2019) · BMC Public Health · doi:10.1186/s12889-019-7458-x · Cited by 46
Maher, L., Dawson, A. J., Wiley, K. E., Hope, K. G., Torvaldsen, S., Lawrence, G. L., & Conaty, S. J. (2014) · BMC Family Practice · doi:10.1186/1471-2296-15-102 · Cited by 45
Tan, K. S., Choi, H., Jiang, X., Yin, L., Seet, J. E., Patzel, V., Engelward, B. P., & Chow, V. T. K. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-587 · Cited by 44
Essink, B. J., Fierro, C. A., Rosen, J., Figueroa, A. L., Zhang, B., Verhoeven, C., Edelman, J. M., & Smolenov, I. V. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.10.021 · Cited by 44
RNA Replicons - A New Approach for Influenza Virus Immunoprophylaxis
Zimmer, G. (2010) · Viruses · doi:10.3390/v2020413 · Cited by 43
Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System
Crane, M. J., Lee, K. M., FitzGerald, E. S., & Jamieson, A. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01421 · Cited by 44
Ishaqui, A. A., Khan, A. H., Sulaiman, S. A. S., Alsultan, M. T., Khan, I., & Naqvi, A. A. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1730180 · Cited by 41
Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts
Koutsonanos, D. G., Esser, E. S., McMaster, S. R., Kalluri, P., Lee, J.-W., Prausnitz, M. R., Skountzou, I., Denning, T. L., Kohlmeier, J. E., & Compans, R. W. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.01.086 · Cited by 42
Rondy, M., Larrauri, A., Casado, I., Alfonsi, V., Pițigoi, D., Launay, O., Syrjänen, R., Gefenaitė, G., Machado, A., Vučina, V. V., et al. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.30.30580 · Cited by 42
Park, M., Yamada, H., Matsushita, K., Kaji, S., Goto, T., Okada, Y., Kosuge, K., & Kitagawa, T. (2011) · Journal of Nutrition · doi:10.3945/jn.110.137547 · Cited by 41
Contribution of respiratory pathogens to influenza-like illness consultations
Bollaerts, K., Antoine, J., Casteren, V. V., Ducoffre, G., Hens, N., & Quoilin, S. (2012) · Epidemiology and Infection · doi:10.1017/s0950268812002506 · Cited by 41
Ferrarini, A., Lava, S. A. G., Simonetti, G. D., Ramelli, G. P., & Bianchetti, M. G. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.12.009 · Cited by 40
Bewick, T. A., Myles, P. R., Greenwood, S., Nguyen‐Van‐Tam, J. S., Brett, S. J., Semple, M. G., Openshaw, P., Bannister, B. A., Read, R. C., Taylor, B. L., et al. (2011) · Thorax · doi:10.1136/thx.2010.151522 · Cited by 40
Immunomodulators targeting MARCO expression improve resistance to postinfluenza bacterial pneumonia
Wu, M., Gibbons, J. G., DeLoid, G. M., Bedugnis, A. S., Thimmulappa, R. K., Biswal, S. S., & Kobzik, L. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00075.2017 · Cited by 42
Kovács, G., Kovács, G., Kaló, Z., Kaló, Z., Jahnz‐Różyk, K., Jahnz‐Różyk, K., Kynčl, J., Kynčl, J., Csohan, A., Csohan, A., et al. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.26886 · Cited by 38
Damm, O., Eichner, M., Rose, M. A., Knuf, M., Wutzler, P., Liese, J. G., Krüger, H., & Greiner, W. (2014) · The European Journal of Health Economics · doi:10.1007/s10198-014-0586-4 · Cited by 38
McKay, S., Oranje, P., Helin, J., Koek, J. H., Kreijveld, E., den Abbeele, P. V., Pohl, U., Bothe, G., Tzoumaki, M. V., Aparicio-Vergara, M., et al. (2021) · Nutrients · doi:10.3390/nu13030963 · Cited by 39
Metadata
- Authors
- Rothberg, M. B., Haessler, S. D., & Brown, R. B.
- Affiliations
- Tufts University (US)
- Corresponding author
- Rothberg, Michael B.
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 121
- Issue
- 4
- Pages
- 258-264
- ISSN
- 0002-9343 (ISSN-L)
- PMC
- PMC7172971
- OpenAlex
- W2039118188
- Cited by
- 456
- References
- 97
- Citations by year
- 2026: 10 · 2025: 22 · 2024: 22 · 2023: 22 · 2022: 22 · 2021: 41 · 2020: 31 · 2019: 21 · 2018: 16 · 2017: 37 · 2016: 24 · 2015: 18 · 2014: 29 · 2013: 24 · 2012: 27
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The American Journal of Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- influenza complications, influenza-associated pneumonia, secondary bacterial pneumonia, Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, influenza vaccination, antiviral resistance, amantadine, neuraminidase inhibitors, influenza mortality, influenza hospitalization, neuromuscular complications, cardiac complications
- MeSH terms
- Aged, Female, Follow-Up Studies, Humans, Infant, Influenza, Human, Influenza Vaccines, Male, Orthomyxoviridae, Pneumonia, Viral, Pregnancy, Severity of Illness Index, United States, Vaccination, Superinfection, Survival Analysis, Age Distribution, Sex Distribution, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review